Clinical Trials on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor in United Kingdom
Total 1 results
-
Rhythm Pharmaceuticals, Inc.CompletedPro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene MutationsUnited States, Israel, Canada, Germany, Greece, Italy, Portugal